| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $125.0M | -17.8% |
| R&D Expense | $3.8M | +34.4% |
| SG&A Expense | $75.1M | -4.6% |
| Operating Income | -$24.5M | +89.9% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$21.5M | +91.5% |
| Income Tax | $52K | -99.9% |
| Net Income | -$21.6M | +93.5% |
| EPS (Basic) | -$0.23 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.6M | -31.1% |
| Short-term Investments | $49.5M | — |
| Accounts Receivable | $54.1M | +13.5% |
| Inventory | $38.3M | +1.7% |
| Current Assets | $202.5M | +18.4% |
| Total Assets | $284.7M | -0.6% |
| Current Liabilities | $114.7M | +22.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.4M | -46.8% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$48.9M | -1679.3% |
| Financing Cash Flow | -$350K | +99.2% |
| Free Cash Flow | $26.4M | -46.1% |
| +95.1% |
| EPS (Diluted) | -$0.23 | +95.1% |
| Long-term Debt |
| $38.8M |
| +0.8% |
| Total Liabilities | $163.7M | +10.3% |
| Stockholders' Equity | $121.1M | -12.3% |